Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: To Continue or Stop Preoperatively-the Debate Continues

被引：0
|
作者：
Rajan, Niraja [1 ]
Joshi, Girish P. [2 ]
机构：
[1] Penn State Hlth, Dept Anesthesiol & Perioperat Med, Hershey, PA USA
[2] Univ Texas Southwestern Med Ctr, Dept Anesthesiol & Pain Management, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
ANESTHESIA AND ANALGESIA | 2024年 / 138卷 / 04期
关键词：
HYPERTENSION; ASSOCIATION; GUIDELINES; MANAGEMENT; RISK;
D O I：
10.1213/ANE.0000000000006825
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：760 / 762
页数：3
相关论文
共 50 条
  • [31] Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
    Lee, Jae-Geun
    Joo, Seung-Jae
    Kim, Song-Yi
    Choi, Joon-Hyouk
    Boo, Ki Yung
    Hwang, Jin-Yong
    Hur, Seung-Ho
    Jeong, Myung Ho
    PLOS ONE, 2023, 18 (03):
  • [32] Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland
    Adnan, Wan A. H. Wan Md
    Zaharan, Nur L.
    Bennett, Kathleen
    Wall, Catherine A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (03) : 458 - 466
  • [33] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits
    Pucci, Mark
    Sarween, Nadia
    Knox, Ellen
    Lipkin, Graham
    Martin, Una
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (02) : 221 - 231
  • [34] Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
    Dezsi, Csaba Andras
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (03) : 167 - 173
  • [35] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: A case for exclusion
    Bubbar, Carolyn D.
    Blackburn, David F.
    Wilson, Merne P.
    Wilson, Thomas W.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 129 - 132
  • [36] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [37] Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Early Period after Kidney Transplantation
    Orlic, Lidija
    Mikolasevic, Ivana
    Sladoje-Martinovic, Branka
    Bubic, Ivan
    Pavletic-Persic, Martina
    Racki, Sanjin
    COLLEGIUM ANTROPOLOGICUM, 2013, 37 (03) : 809 - 814
  • [38] Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners
    Walker, Sophie L. M.
    Abbott, Tom E. F.
    Brown, Katherine
    Pearse, Rupert M.
    Ackland, Gareth L.
    PEERJ, 2018, 6
  • [39] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
    van Sloten, Thomas T.
    Souverein, Patrick C.
    Stehouwer, Coen D. A.
    Driessen, Johanna H. M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (05) : 594 - 603
  • [40] USE OF ANGIOTENSIN RECEPTOR BLOCKERS AFTER ANGIOEDEMA WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR
    Haymore, Bret R.
    DeZee, Kent J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (01) : 83 - 84
12345